Whether a 'Cardio Risk Check' can help with menopause cannot be determined from the provided context. The knowledge base contains no data on such a test or menopause-specific risk factors. Menopause involves hormonal shifts (e.g., declining estrogen) that alter cardiovascular risk, including lipid changes and vascular function. A generic cardio risk test – whether DNA-based, blood-based, or microbiome-based – might theoretically flag individual tendencies, but there is no evidence from the given materials to support its utility specifically for menopause. Many direct-to-consumer tests rely on markers with limited clinical validation (e.g., FADS1 variants for omega-3 metabolism, APOE for general risk). The evidence level is 'unclear' or 'marketing'. Women in menopause should prioritize established cardiovascular prevention (exercise, diet, blood pressure management) rather than relying on unproven genetic tests. Consulting a healthcare provider before using such tests is strongly advised.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-861638dbaf75bef87606902f